author-photo

Kathleen Glick

13

Papers

331

Citations

Citation Trend

Filter By

Papers (10) Sort By

Journal Conference Others

Feasibility of pre-operative mTOR inhibitor Sirolimus in children and young adults with desmoid tumor

2019
Show All
- Source
- Cite
- Save
Citations (0)
Abnormalities Of 12p Are Associated With High-Risk Acute Myeloid Leukemia: A Children’s Oncology Group Report

2013 Blood
Show All
- Source
- Cite
- Save
Citations (7)
Elevated Expression of miR-181a and miR-155 Identify Pediatric AML Patients at High Risk of Induction Failure, A Report from Children's Oncology Group.

2012 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Cryptic NUP98/NSD1 Translocations Are Highly Prevalent in FLT3/ITD-Positive Acute Myeloid Leukemia and Lead to High Rate of Induction Failure. Report From Children9s Oncology Group

2012 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Presence of Residual Disease Detected by Multidimensional Flow Cytometry Identifies Patients with AML At High Risk of Relapse – a Report From the Children's Oncology Group,

2011 Blood
Show All
- Source
- Cite
- Save
Citations (1)
Multidimensional Flow Cytometry Significantly Improves Upon the Morphologic Assessment of Post-Induction Marrow Remission Status – Comparison of Morphology and Multidimensional Flow Cytometry; A Report From the Children9s Oncology Group AML Protocol AAML0531

2011 Blood
Show All
- Source
- Cite
- Save
Citations (7)
Severe Toxicities During Pediatric Acute Myeloid Leukemia Chemotherapy: A Report From the Children's Oncology Group.

2010 Blood
Show All
- Source
- Cite
- Save
Citations (7)
Flow Cytometric Assessment of Post Induction Response In Patients with Sub-Optimal Morphologic Response to Induction Chemotherapy- A Report From the Children9s Oncology Group AML Protocol AAML0531

2010 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Remission Rates In Childhood Acute Myeloid Leukemia (AML) Utilizing a Dose-Intensive Induction Regimen with or without Gemtuzumab Ozogamicin (GO): Initial Results From the Children's Oncology Group Phase III Trial, AAML0531

2010 Blood
Show All
- Source
- Cite
- Save
Citations (13)
COG AAML03P1: Efficacy and Safety in a Pilot Study of Intensive Chemotherapy Including Gemtuzumab in Children Newly Diagnosed with Acute Myeloid Leukemia (AML)

2008 Blood
Show All
- Source
- Cite
- Save
Citations (21)